Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Girerd

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Contemporary Clinical Trials|May 11, 2007
Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT)Joshua S Benner, Spencer B Cherry, Leif Erhardt, et al.
Journal of Hypertension|July 24, 2018
Early central blood pressure elevation in adult patients with 21-hydroxylase deficiencyDavid Rosenbaum, Antonio Gallo, Gaelle Lethielleux, et al.
Blood Pressure|July 9, 2008
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trialSverre E Kjeldsen, Gordon T McInnes, Giuseppe Mancia, et al.
Journal of the American Medical Directors Association|November 3, 2020
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics PatientsBastien Genet, Jean-Sébastien Vidal, Adrien Cohen, et al.
Journal of Hypertension|June 24, 2006
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialSverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, et al.
Hypertension (Dallas, Tex. : 1979)|August 30, 2021
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High RiskStephane Laurent, Gilles Chatellier, Michel Azizi, et al.
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension)Philippe Gosse, Antoine Cremer, Helena Pereira, et al.
Journal of the American Heart Association|October 12, 2017
Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) TrialPierre-Yves Courand, Helena Pereira, Costantino Del Giudice, et al.
European Heart Journal|May 22, 2025
Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trialNiki Procopi, Michel Zeitouni, Mathieu Kerneis, et al.
Circulation|September 1, 2016
Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) TrialMichel Azizi, Helena Pereira, Idir Hamdidouche, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Contemporary Clinical Trials|May 11, 2007
Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT)Joshua S Benner, Spencer B Cherry, Leif Erhardt, et al.
Journal of Hypertension|July 24, 2018
Early central blood pressure elevation in adult patients with 21-hydroxylase deficiencyDavid Rosenbaum, Antonio Gallo, Gaelle Lethielleux, et al.
Blood Pressure|July 9, 2008
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trialSverre E Kjeldsen, Gordon T McInnes, Giuseppe Mancia, et al.
Journal of the American Medical Directors Association|November 3, 2020
COVID-19 In-Hospital Mortality and Use of Renin-Angiotensin System Blockers in Geriatrics PatientsBastien Genet, Jean-Sébastien Vidal, Adrien Cohen, et al.
Journal of Hypertension|June 24, 2006
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trialSverre E Kjeldsen, Stevo Julius, Giuseppe Mancia, et al.
Hypertension (Dallas, Tex. : 1979)|August 30, 2021
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High RiskStephane Laurent, Gilles Chatellier, Michel Azizi, et al.
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension)Philippe Gosse, Antoine Cremer, Helena Pereira, et al.
Journal of the American Heart Association|October 12, 2017
Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) TrialPierre-Yves Courand, Helena Pereira, Costantino Del Giudice, et al.
European Heart Journal|May 22, 2025
Beta-blocker interruption effects on blood pressure and heart rate after myocardial infarction: the AβYSS trialNiki Procopi, Michel Zeitouni, Mathieu Kerneis, et al.
Circulation|September 1, 2016
Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) TrialMichel Azizi, Helena Pereira, Idir Hamdidouche, et al.
Pageof 7